AORT

AORT

Artivion Inc

Artivion Inc. manufactures and distributes medical devices and implantable human tissues for cardiac and vascular surgeries, focusing on aortic diseases. Key products include heart valves, stent grafts, and surgical sealants, primarily sold to healthcare facilities.

โš•๏ธ Healthcare NYSE Listed 1993 $ USD
$1,000 invested 30 years ago โ†’$3,162today

Score Overview

1 Year
Score
Net Growth-132.40%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth6.83%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.9
Net Growth78.66%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth57.77%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth-129.37%
Net Trend40%
Net Income Consistency
Rev Growth161.38%
Rev Trend90%
Revenue Consistency
20 Years
Score4.2
Net Growth-8x
Net Trend50%
Net Income Consistency
Rev Growth479.84%
Rev Trend95%
Revenue Consistency
30 Years
Score
Net Growth-181.15%
Net Trend53%
Net Income Consistency
Rev Growth12x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth-5x
Net Trend58%
Net Income Consistency
Rev Growth22x
Rev Trend91%
Revenue Consistency

See the full market ranking โ†’

Artivion Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 253M to $ 441M and net income went from -$ 16M to $ 9M. Revenue increased in every one of those 5 years; net income in 2.

Across Artivion Inc's full reported history, from 1993 to 2025, revenue grew from $ 21M to $ 441M and net income grew from $ 600K to $ 9M. Revenue increased in 91% of the years measured; net income in 58%.

Artivion Inc currently holds a 20-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 28.64โ€”
1 Year2025-08-12
$ 43.85-34.69%
5 Years2021-08-12
$ 25.5012.31%
10 Years2016-08-12
$ 15.5184.66%
20 Years2006-08-11
$ 5.23448.10%
30 Years1996-08-12
$ 9.06216.17%
All Time1993-02-12
$ 3.817x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 471M-$ 3M$ 77M
2025$ 441M$ 9M$ 64M
2024$ 388M-$ 13M$ 53M
2023$ 354M-$ 30M$ 58M
2022$ 313M-$ 19M$ 39M
2021$ 298M-$ 14M$ 55M
2020$ 253M-$ 16M$ 61M
2019$ 276M$ 1M$ 33M
2018$ 262M-$ 3M$ 41M
2017$ 189M$ 3M$ 40M
2016$ 180M$ 10M$ 57M
2015$ 145M$ 4M$ 43M
2014$ 144M$ 7M$ 33M
2013$ 140M$ 16M$ 42M
2012$ 131M$ 7M$ 18M
2011$ 119M$ 7M$ 21M
2010$ 116M$ 3M$ 35M
2009$ 111M$ 8M$ 30M
2008$ 105M$ 32M$ 17M
2007$ 94M$ 7M$ 17M
2006$ 81M$ 365K$ 8M
2005$ 69M-$ 19M$ 11M
2004$ 62M-$ 18M$ 8M
2003$ 59M-$ 32M$ 10M
2002$ 77M-$ 27M$ 24M
2001$ 87M$ 9M$ 33M
2000$ 77M$ 7M$ 38M
1999$ 66M$ 4M$ 30M
1998$ 60M$ 6M$ 12M
1997$ 50M$ 4M$ 100K
1996$ 37M$ 3M$ 1M
1995$ 29M$ 2M$ 200K
1994$ 23M$ 1M$ 2M
IPO1993$ 21M$ 600K$ 1M

Explore beyond AORT

You're looking at Artivion Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies